Editorial for “Exploring the Dynamics of Ischemia and Reactive Hyperemia With Skeletal Muscle Blood Oxygen Level Dependent MRI in Patients With Peripheral Artery Disease, Age‐Matched Controls, and Young Healthy Subjects”

The pathophysiology of peripheral artery disease (PAD) extends far beyond macrovascular stenosis. The resulting tissue ischemia and microcirculatory dysfunction are critical determinants of symptom severity and patient prognosis. In recent years, blood oxygenation level-dependent (BOLD) MRI has gained significant attention in PAD research as a non-invasive tool for assessing tissue oxygenation. By employing cuff-induced occlusion and release to provoke an ischemia-hyperemia response and observing dynamic T2* signal changes, BOLD MRI can indirectly reveal the regulatory capacity of the skeletal muscle microvasculature. Previous studies have demonstrated that quantitative parameters derived from BOLD signal curves hold potential clinical value for diagnosing PAD, assessing disease severity, and evaluating prognosis 1-3. However, a common tendency in many studies is to reduce the complexity of BOLD signal curves to a few predefined parameters (e.g., time to peak TTP and hyperemia peak value HPV). While this simplification facilitates statistical analysis, it risks overlooking the rich physiological and pathological information embedded within the curve's dynamic morphology. Against this backdrop, the study published in this issue of the Journal of Magnetic Resonance Imaging, “Exploring the Dynamics of Ischemia and Reactive Hyperemia with Skeletal Muscle Blood Oxygen Level Dependent MRI in Patients with Peripheral Artery Disease, Age-matched Controls, and Young Healthy Subjects” provides crucial insights 4. Moving beyond the validation of established parameters, the authors conducted a detailed survey of the curves and developed novel quantification tools, shifting the perspective towards atypical features and thereby opening new avenues for understanding microvascular heterogeneity in PAD. A primary contribution of this work is its systematic characterization and quantification of previously overlooked BOLD curve traits, expanding the focus from the hyperemic phase alone to the entire ischemia–hyperemia cycle. For instance, the study identified a non-monotonic decrease in T2* during cuff occlusion, termed a “positive deviation,” in a considerable proportion of patients. The authors designed two new metrics, posDevLength and posDevMagn, to quantify this phenomenon. Furthermore, the quantification of the post-deflation undershoot transient magnitude (∆UST) deepens our understanding of the complex flow–oxygenation coupling dynamics in the initial moments of reperfusion 5. More importantly, these newly identified curve features exhibit high variability within the patient cohort. This variability may no longer be considered mere noise but rather a potential signal indicating the existence of distinct microvascular phenotypes in PAD. While traditional parameters like TTP effectively differentiate patients from healthy controls, they may fail to capture intra-group differences among patients. The complex dynamics observed in this study, such as T2* interdependencies between different muscles, might reveal more specific pathophysiological alterations, for example, related to intermuscular venous communication and valvular function 6. This paves the way for evolving BOLD MRI from a diagnostic tool into a phenotyping tool, potentially enabling more individualized treatment strategies 7. The study also adopts a rigorous approach to re-evaluating the impact of technical factors on the results. Through supplementary experiments, the authors confirmed that insufficient cuff pressure produces a characteristic curve pattern featuring an absent ischemic plateau and a blunted hyperemic response. This finding provides essential quality control guidance for the skeletal BOLD MRI research field, emphasizing the necessity of excluding technical artifacts before physiological interpretation to avoid misinterpreting technical failure as severe microvascular dysfunction 8. Naturally, this exploratory study has limitations, including its limited sample size and suboptimal data quality from certain muscles. Reproducibility studies are also very important for newly developed parameters before their clinical application. Moreover, future work should validate the robustness and clinical relevance of these new metrics in larger, multi-center cohorts. Integrating BOLD MRI with complementary techniques like arterial spin labeling (ASL) 9 and near-infrared spectroscopy (NIRS) 10 will be key to constructing a more comprehensive assessment framework for lower limb ischemia. In conclusion, this study emphasizes a conceptual transition from the simple extraction of quantitative parameters to a comprehensive interpretation of the entire signal curve in skeletal muscle BOLD MRI. BOLD MRI offers a dynamic and detailed representation of microvascular function, and a thorough analysis of its temporal characteristics enables deeper insights into the complex microcirculatory alterations in PAD. Such an interpretative approach may facilitate the translation of BOLD MRI from a research tool to a clinically applicable technique, thereby contributing to more precise and individualized management of patients with PAD.